The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors.

Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

The U.S. Food and Drug Administration (FDA) is issuing an Early Alert for specific glucose monitoring systems after Abbott ...

Abbott Laboratories is cited for four key alleged violations related to the production of its Freestyle Libre continuous ...

The FDA has escalated the recall of specific Abbott FreeStyle Libre 3 and 3 Plus CGMs to Class I, the highest level of ...

Add Yahoo as a preferred source to see more of our stories on Google. FreeStyle Libre 3 sensor by Abbott Image by Adobe Medical device giant Abbott announced on Sunday that it is recalling ...

Quick Read Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio.

In early January 2026, Abbott Laboratories unveiled Libre Assist, an AI-powered feature within its Libre app that helps U.S. diabetes patients predict the glucose impact of meals in real time by ...

Abbott Laboratories ABT presented late-breaking clinical data that demonstrate the FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor. The results were presented at the ...

Image above: ad for Freestyle Libre continuous glucose monitor for diabetics. “In terms of sales dollars, Libre has become the most successful medical device in history,” Abbott CEO Robert Ford ...

Please provide your email address to receive an email when new articles are posted on . A voluntary medical device correction warned users of three Abbott FreeStyle Libre readers about the risk of ...